Showing results (1711-1720 of 3,196) with videos related to

Sort By:
Pageof 320
Translational Oncology|January 30, 2022
TIM-3 shuttled by MV3 cells-secreted exosomes inhibits CD4+ T cell immune function and induces macrophage M2 polarization to promote the growth and metastasis of melanoma cellsXinghui Li, Yu Liu, Li Yang, et al.
Translational Oncology|March 13, 2022
TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathwayJiayang Cai, Lun Gao, Yixuan Wang, et al.
Translational Oncology|April 2, 2022
Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinomaMaria Davern, Noel E Donlon, Fiona O' Connell, et al.
Translational Oncology|March 27, 2022
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells responseTristan Rupp, Laurie Genest, David Babin, et al.
Translational Oncology|March 25, 2022
Force-feeding malignant mesothelioma stem-cell like with exosome-delivered miR-126 induces tumour cell killingFederica Monaco, Laura De Conti, Simone Vodret, et al.
Translational Oncology|April 5, 2022
3D patient-derived tumor models to recapitulate pediatric brain tumors In VitroMin D Tang-Schomer, Harshpreet Chandok, Wei-Biao Wu, et al.
Translational Oncology|September 3, 2018
Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation ResistanceV O Oria, P Bronsert, A R Thomsen, et al.
Translational Oncology|October 7, 2018
Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33Saritha Tantravedi, Farhad Vesuna, Paul T Winnard, et al.
Translational Oncology|March 8, 2022
Punicalagin promotes autophagic degradation of human papillomavirus E6 and E7 proteins in cervical cancer through the ROS-JNK-BCL2 pathwayXialin Xie, Liuyi Hu, Lulu Liu, et al.
Translational Oncology|February 23, 2022
PDE4D targeting enhances anti-tumor effects of sorafenib in clear cell renal cell carcinoma and attenuates MAPK/ERK signaling in a CRAF-dependent mannerMinghua Cao, Karol Nawalaniec, Amrendra K Ajay, et al.
Pageof 320